Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lumavita AG

Latest From Lumavita AG

Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita

Many pharmaceutical and biotech companies devote themselves to the discovery and development of novel drugs for unmet medical needs. However, with R&D costs and regulatory hurdles multiplying, and much of the low-hanging therapeutic fruit already picked, a growing number of firms are taking a different, pragmatic approach. They are looking in a new light at existing compounds that may have been dropped in development for reasons that are no longer insuperable, or even withdrawn from the market. One such firm is Lumavita, whose CEO Nicholas Benedict spoke to Scrip's companies editor Eleanor Malone.

Cancer Infectious Diseases

Private investment round-up: June 2009

The total investments secured by private companies slumped once more in June, disappointing onlookers hoping that May's healthy performance was a sign of recovery in the market, a Scrip analysis has found.

Gastrointestinal Cancer

Lumavita expands series A fundraising

Lumavita, a Swiss start-up biopharmaceutical company focused on women's health, has raised another CHF6 million (€4 million), bringing its series A total to CHF24 million.

Infectious Diseases Switzerland

Recent Financings of Private Companies (10/2008)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals